Clinical trials
Recruiting Phase 2 Uterine Cervical Neoplasms trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
69 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2016 | 1 |
| 2018 | 1 |
| 2021 | 2 |
| 2022 | 4 |
| 2023 | 10 |
| 2024 | 17 |
| 2025 | 26 |
| 2026 | 8 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Recruiting | 69 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Fujian Cancer Hospital | 3 |
| Tianjin Medical University Cancer Institute and Hospital | 3 |
| Tongji Hospital | 3 |
| Obstetrics & Gynecology Hospital of Fudan University | 2 |
| Sichuan Baili Pharmaceutical Co., Ltd. | 2 |
| Abramson Cancer Center at Penn Medicine | 1 |
| AstraZeneca | 1 |
| Bayer | 1 |
| Baylor College of Medicine | 1 |
| Cancer Institute and Hospital, Chinese Academy of Medical Sciences | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Uterine Cervical Neoplasms | 69 |
| Endometrial Neoplasms | 11 |
| Ovarian Neoplasms | 9 |
| Vulvar Neoplasms | 8 |
| Vaginal Neoplasms | 7 |
| Carcinoma, Non-Small-Cell Lung | 6 |
| Breast Neoplasms | 4 |
| Esophageal Neoplasms | 4 |
| Melanoma | 4 |
| Neoplasm Metastasis | 4 |
Trials
Showing 1 to 25 of 69. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.